EY Recommends Focusing On Fundamentals, Waiting For Prime Deal Conditions

 
• By Joseph Haas
  
Person jumping over a hole, depicting financial volatility
Volatility in finance and policy outcomes creates a good time for pharma to focus on fundamentals, says EY (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Strategy